|
1
|
World Cancer Report. International Agency
for Research on Cancer. 2008, Available at. http://www.iarc.fr/en/publications/pdfs-online/wcr/2008/index.phpApril
29–2016
|
|
2
|
Dittmer J and Rody A: Cancer stem cells in
breast cancer. Histol Histopathol. 28:827–838. 2013.PubMed/NCBI
|
|
3
|
Corcoran KE, Trzaska KA, Fernandes H,
Bryan M, Taborga M, Srinivas V, Packman K, Patel PS and Rameshwar
P: Mesenchymal stem cells in early entry of breast cancer into bone
marrow. PLoS One. 3:e25632008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Terunuma H, Deng X, Dewan Z, Fujimoto S
and Yamamoto N: Potential role of NK cells in the induction of
immune responses: Implications for NK cell-based immunotherapy for
cancers and viral infections. Int Rev Immunol. 27:93–110. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tseng HC, Arasteh A, Paranjpe A, Teruel A,
Yang W, Behel A, Alva JA, Walter G, Head C, Ishikawa TO, et al:
Increased lysis of stem cells but not their differentiated cells by
natural killer cells; de-differentiation or reprogramming activates
NK cells. PLoS One. 5:e115902010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yin T, Wang G, He S, Liu Q, Sun J and Wang
Y: Human cancer cells with stem cell-like phenotype exhibit
enhanced sensitivity to the cytotoxicity of IL-2 and IL-15
activated natural killer cells. Cell Immunol. 300:41–45. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Takayama T, Sekine T, Makuuchi M, Yamasaki
S, Kosuge T, Yamamoto J, Shimada K, Sakamoto M, Hirohashi S, Ohashi
Y and Kakizoe T: Adoptive immunotherapy to lower postsurgical
recurrence rates of hepatocellular carcinoma: A randomised trial.
Lancet. 356:802–807. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kono K, Takahashi A, Ichihara F, Amemiya
H, Iizuka H, Fujii H, Sekikawa T and Matsumoto Y: Prognostic
significance of adoptive immunotherapy with tumor-associated
lymphocytes in patients with advanced gastric cancer: A randomized
trial. Clin Cancer Res. 8:1767–1771. 2002.PubMed/NCBI
|
|
9
|
Egawa K: Immuno-cell therapy of cancer in
Japan. Anticancer Res. 24:3321–3326. 2004.PubMed/NCBI
|
|
10
|
Takada M, Terunuma H, Deng X, Dewan MZ,
Saji S, Kuroi K, Yamamoto N and Toi M: Refractory lung metastasis
from breast cancer treated with multidisciplinary therapy including
an immunological approach. Breast Cancer. 18:64–67. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Domschke C, Ge Y, Bernhardt I, Schott S,
Keim S, Juenger S, Bucur M, Mayer L, Blumenstein M, Rom J, et al:
Long-term survival after adoptive bone marrow T cell therapy of
advanced metastasized breast cancer: Follow-up analysis of a
clinical pilot trial. Cancer Immunol Immunother. 62:1053–1060.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kotsakis A, Sarra E, Peraki M, Koukourakis
M, Apostolaki S, Souglakos J, Mavromanomakis E, Vlachonikolis J and
Georgoulias V: Docetaxel-induced lymphopenia in patients with solid
tumors: A prospective phenotypic analysis. Cancer. 89:1380–1386.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bloom HJ and Richardson WW: Histological
grading and prognosis in breast cancer; a study of 1409 cases of
which 359 have been followed for 15 years. Br J Cancer. 11:359–377.
1957. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sobin LH, Gospodarowicz MK and Wittekind
CH: TNM Classification of Malignant Tumors. 7th edition.
Wiley-Blackwell; Oxford: 2009
|
|
15
|
Premkumar S, Dedeepiya VD, Terunuma H,
Senthilkumar R, Srinivasan T, Reena HC, Preethy S and Abraham SJ:
Cell based autologous immune enhancement therapy (AIET) after
radiotherapy in a locally advanced carcinoma of the cervix. Case
Rep Oncol Med. 2013:9030942013.PubMed/NCBI
|
|
16
|
Manjunath SR, Ramanan G, Dedeepiya VD,
Terunuma H, Deng X, Baskar S, Senthilkumar R, Thamaraikannan P,
Srinivasan T, Preethy S and Abraham SJ: Autologous immune
enhancement therapy in recurrent ovarian cancer with metastases: A
case report. Case Rep Oncol. 5:114–118. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dedeepiya V, Terunuma H, Deng X, Baskar S,
Manjunath S, Senthilkumar R, Murugan P, Thamaraikannan P,
Srinivasan T, Preethy S and Abraham SJ: A comparative analysis of
in vitro expansion of natural killer cells of a patient with
autoimmune haemolytic anaemia and ovarian cancer with patients with
other solid tumours. Oncol Lett. 3:435–440. 2012.PubMed/NCBI
|
|
18
|
Gogia A, Raina V, Deo SV, Shukla NK,
Mohanti BK and Sharma DN: Inflammatory breast cancer: A single
centre analysis. Asian Pac J Cancer Prev. 15:3207–3210. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sevko A, Sade-Feldman M, Kanterman J,
Michels T, Falk CS, Umansky L, Ramacher M, Kato M, Schadendorf D,
Baniyash M and Umansky V: Cyclophosphamide promotes chronic
inflammation-dependent immunosuppression and prevents antitumor
response in melanoma. J Invest Dermatol. 133:1610–1619. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tsavaris N, Kosmas C, Vadiaka M,
Kanelopoulos P and Boulamatsis D: Immune changes in patients with
advanced breast cancer undergoing chemotherapy with taxanes. Br J
Cancer. 87:21–27. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tai LH, de Souza CT, Bélanger S, Ly L,
Alkayyal AA, Zhang J, Rintoul JL, Ananth AA, Lam T, Breitbach CJ,
et al: Preventing postoperative metastatic disease by inhibiting
surgery-induced dysfunction in natural killer cells. Cancer Res.
73:97–107. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fridman WH, Remark R, Goc J, Giraldo NA,
Becht E, Hammond SA, Damotte D, Dieu-Nosjean MC and Sautès-Fridman
C: The immune microenvironment: A major player I human cancers. Int
Arch Allergy Immunol. 164:13–26. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sznurkowski JJ, Zawrocki A and Biernat W:
Subtypes of cytotoxic lymphocytes and natural killer cells
infiltrating cancer nests correlate with prognosis in patients with
vulvar squamous cell carcinoma. Cancer Immunol Immunother.
63:297–303. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shafer D, Smith MR, Borghaei H, Millenson
MM, Li T, Litwin S, Anad R and Al-Saleem T: Low NK cell counts in
peripheral blood are associated with inferior overall survival in
patients with follicular lymphoma. Leuk Res. 37:1213–1235. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hanna N and Fidler IJ: Role of natural
killer cells in the destruction of circulating tumor emboli. J Natl
Cancer Inst. 65:801–809. 1980. View Article : Google Scholar : PubMed/NCBI
|
